H-L-beta-HAG-OH

H-L-beta-HAG-OH is an L-configured β-amino acid derivative featuring a β-amino group and a carboxylic acid functionality, with stereochemical definition at the β-carbon that governs conformational preferences during peptide coupling and downstream transformations. The molecule's amino and acid groups enable formation of amide bonds under standard peptide chemistry conditions, while the β-amino topology can influence backbone geometry relative to α-amino acids. The presence of a free carboxyl group supports salt formation and controlled solubility for handling, and the free β-amino functionality can participate in derivatization or require protection to suppress side reactions. As a chiral amino acid building block, H-L-beta-HAG-OH serves as a stereochemically defined intermediate for peptide analog construction, amino acid modification workflows, and synthetic methodology development.

1. Peptide Synthesis

H-L-beta-HAG-OH is applied in peptide synthesis and peptide analog construction where β-amino acid incorporation enables access to altered backbone spacing and β-amide linkages. The β-amino and carboxylic acid groups support peptide coupling chemistry after appropriate activation of the acid and management of the amino nucleophile, with stereochemistry at the β-center providing defined stereochemical outcomes in the resulting amide. Protection-group strategies, such as temporary N-protection followed by coupling and final deprotection, can be used to control chemoselectivity during chain assembly. The resulting β-peptide segments can be carried into longer synthetic sequences for structure-activity relationship studies and scaffold diversification in peptide science.

2. Amino Acid Derivatization

H-L-beta-HAG-OH is suitable for amino acid derivatization workflows that convert the free β-amino and carboxyl functionalities into functional handles for subsequent synthetic steps. The β-amino group can be selectively functionalized to introduce electrophilic or protected forms for controlled reactivity, while the carboxyl group can be transformed into activated esters, amides, or salts to tune solubility and coupling behavior. Chemoselective protection and deprotection strategies help manage potential side reactions arising from the proximity of amino and acid groups during multi-step synthesis. Downstream derivatives prepared from H-L-beta-HAG-OH can serve as intermediates for medicinal chemistry fragments, peptidomimetic building blocks, and process-compatible chiral intermediates.

3. Chiral Building Block Development

H-L-beta-HAG-OH is used as a chiral amino acid intermediate for stereoselective synthesis planning in fine chemical and process chemistry contexts. The defined L-configuration at the β-carbon provides a stereochemical "anchor" that can be retained through protection, activation, and coupling steps, supporting consistent stereochemical outcomes in β-substituted products. The amino acid's functional groups enable conversion into protected amino acid derivatives, including N-protected forms for iterative chain extension, as well as activated carboxy derivatives for fragment coupling. The chiral nature of H-L-beta-HAG-OH also supports its role in preparing enantiopure standards and stereochemically defined analogs for analytical characterization and method development.

4. Chemical Biology Probes

H-L-beta-HAG-OH can be incorporated into chemical biology probe design where β-amino acid motifs help modulate peptide stability, protease resistance, and conformational behavior. The β-amino and carboxy groups enable conjugation-ready intermediates after N-protection and subsequent functional group installation, allowing attachment to tags, linkers, or affinity handles used in biomolecular recognition studies. Side-chain or backbone modifications derived from H-L-beta-HAG-OH can support the construction of peptide-like probes that participate in molecular recognition while maintaining defined stereochemistry. The resulting β-peptide or β-amide-containing constructs can be used as tools for studying binding interactions, substrate preferences, or biomolecular assembly in applied biochemical research.

5. Pharmaceutical Intermediate Preparation

H-L-beta-HAG-OH is applied as a pharmaceutical intermediate in the synthesis of peptidomimetic and β-amino acid-containing building blocks used in research-grade drug discovery chemistry. The free carboxylic acid and β-amino group support conversion into activated derivatives and protected intermediates that fit common peptide coupling and fragment assembly workflows. N-protection strategies can be employed to enable selective coupling at the carboxyl group while preserving the stereochemical integrity of the β-center through multi-step sequences. The downstream β-amino acid derivatives prepared from H-L-beta-HAG-OH can feed into larger synthetic routes for structure-activity relationship studies and stereodefined candidate molecule generation.

6. Process Chemistry Intermediate

H-L-beta-HAG-OH is suitable for process chemistry intermediate preparation where functional group management and reproducible handling of chiral amino acids are central to scalable synthesis. The amino acid's acid-base properties support salt formation and controlled solubility, which can be leveraged to improve material handling during manufacturing-oriented workflows. Chemoselective protection of the β-amino group and activation of the carboxyl group can be used to create coupling-ready intermediates that minimize side reactions in downstream steps. The β-amino acid framework also supports manufacturing-compatible routes to protected amino acid derivatives and β-amide-containing intermediates used in fine chemical synthesis and specialty chemical production.

1. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

2. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

4. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

5. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation